Header Logo

Connection

ASHOK KUMAR to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications ASHOK KUMAR has written about Histone Deacetylase Inhibitors.
ASHOK KUMAR
Connection Strength
0.063
Histone Deacetylase Inhibitors
  1. Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest New Drugs. 2008 Feb; 26(1):81-7.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.